(Q46276232)

English

Enhancement of the anti-tumor immune response using a combination of interferon-gamma and B7 expression in an experimental mammary carcinoma

scientific article published in July 1998

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

Enhancement of the anti-tumor immune response using a combination of interferon-gamma and B7 expression in an experimental mammary carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

author name string

A A Hurwitz

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

S E Townsend

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

T F Yu

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

J A Wallin

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

J P Allison

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

language of work or name

0 references

publication date

1 July 1998

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

77

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

107-113

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

CD28-B7 interactions in T-cell activation.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Manipulation of costimulatory signals to enhance antitumor T-cell responses.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Major histocompatibility complex class II+B7-1+ tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell-mediated anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Interferon gamma: a master key in the immune system

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Interferon—A Major Regulator of Natural Killer Cell-Mediated Cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

A reassessment of the role of B7-1 expression in tumor rejection.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Identifiers

10.1002/(SICI)1097-0215(19980703)77:1<107::AID-IJC17>3.0.CO;2-B

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46276232&oldid=2102979269"